Measurement	O
of	O
IgA1	O
content	O

IgA1	O
content	O
in	O
the	O
supernatant	B-Organism_substance
from	O
each	O
culture	B-Cell
well	O
was	O
measured	O
in	O
duplicate	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
.	O

All	O
incubations	O
were	O
performed	O
at	O
room	O
temperature	O
except	O
for	O
capture	O
antibody	O
coating	O
.	O

Briefly	O
,	O
96	O
-	O
well	O
immunoplates	O
(	O
Thermo	O
Fisher	O
Scientific	O
,	O
Waltham	O
,	O
MA	O
,	O
USA	O
)	O
were	O
coated	O
with	O
5	O
microg	O
/	O
mL	O
of	O
F	O
(	O
ab	O
'	O
)	O
2	O
fragment	O
goat	O
anti	O
-	O
human	O
IgA	O
antibody	O
(	O
Jackson	O
ImmunoResearch	O
Laboratories	O
,	O
West	O
Grove	O
,	O
PA	O
,	O
USA	O
)	O
,	O
in	O
phosphate	O
-	O
buffered	O
saline	O
(	O
PBS	O
)	O
at	O
4degreesC	O
overnight	O
.	O

After	O
three	O
washes	O
with	O
PBS	O
containing	O
0	O
.	O
05	O
%	O
Tween	O
-	O
20	O
(	O
PBST	O
)	O
,	O
plates	O
were	O
blocked	O
by	O
adding	O
PBS	O
containing	O
1	O
%	O
bovine	O
serum	B-Organism_substance
albumin	O
(	O
BSA	O
)	O
to	O
the	O
wells	O
for	O
90	O
min	O
.	O

Next	O
,	O
50	O
microL	O
of	O
supernatant	B-Organism_substance
sample	I-Organism_substance
or	O
standard	O
human	O
IgA1	O
(	O
CALBIOCHEM	O
,	O
La	O
Jolla	O
,	O
CA	O
,	O
USA	O
)	O
was	O
added	O
to	O
the	O
reaction	O
wells	O
and	O
then	O
incubated	O
for	O
90	O
min	O
.	O

After	O
three	O
washes	O
,	O
0	O
.	O
75	O
microg	O
/	O
mL	O
alkaline	O
phosphatase	O
conjugated	O
goat	O
anti	O
-	O
human	O
IgA	O
(	O
Southern	O
Biotechnology	O
Associates	O
,	O
Birmingham	O
,	O
AL	O
,	O
USA	O
)	O
in	O
1	O
%	O
BSA	O
/	O
PBS	O
was	O
added	O
to	O
the	O
reaction	O
wells	O
and	O
then	O
incubated	O
for	O
90	O
min	O
.	O

Plates	O
were	O
washed	O
three	O
times	O
and	O
developed	O
with	O
a	O
substrate	O
solution	O
of	O
1	O
mg	O
/	O
mL	O
p	O
-	O
nitrophenyl	O
phosphate	O
disodium	O
salt	O
(	O
SIGMA	O
,	O
St	O
.	O
Louis	O
,	O
MO	O
,	O
USA	O
)	O
in	O
0	O
.	O
1	O
M	O
glycine	O
buffer	O
containing	O
1	O
mM	O
MgCl2	O
,	O
1	O
mM	O
ZnCl2	O
,	O
pH	O
10	O
.	O
4	O
.	O

The	O
optical	O
density	O
at	O
405	O
nm	O
was	O
determined	O
in	O
a	O
microplate	O
reader	O
(	O
Benchmark	O
PlusTM	O
Bio	O
-	O
Rad	O
Laboratories	O
,	O
Hercules	O
,	O
CA	O
,	O
USA	O
)	O
.	O

IgA1	O
concentration	O
in	O
unknown	O
duplicate	O
samples	B-Organism_substance
was	O
determined	O
by	O
interpolation	O
of	O
the	O
respective	O
optical	O
density	O
into	O
the	O
appropriate	O
standard	O
curve	O
.	O

IgG	O
and	O
IgM	O
contents	O
in	O
the	O
supernatant	B-Organism_substance
were	O
measured	O
using	O
sandwich	O
ELISA	O
(	O
IMMUNOtek	O
(	O
R	O
)	O
,	O
ZeptoMetrix	O
Corporation	O
,	O
Buffalo	O
,	O
NY	O
,	O
USA	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

